Patient-Reported Outcomes in Psoriatic Arthritis

Ana-Maria Orbai, Alexis Ogdie

Research output: Contribution to journalArticle

Abstract

Patient-reported outcome (PRO) measures are an important component to assessing disease impact and therapy response in patients with psoriatic arthritis (PsA). Overall, there are few PsA-specific PROs. Most PROs used in PsA are borrowed from other diseases (eg, rheumatoid arthritis and ankylosing spondylitis) or general population PROs. PROs are used in PsA clinical trials and in the clinical management of PsA. In this review, we discuss the most commonly used PRO in PsA, including their inclusion in composite measures. Future studies may be helpful to determine the best performing PROs in patients with PsA.

Original languageEnglish (US)
JournalRheumatic Disease Clinics of North America
DOIs
StateAccepted/In press - 2016

Fingerprint

Psoriatic Arthritis
Ankylosing Spondylitis
Patient Reported Outcome Measures
Rheumatoid Arthritis
Clinical Trials
Population

Keywords

  • Composite measures
  • Outcome measure
  • Patient reported outcome
  • Psoriatic arthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Patient-Reported Outcomes in Psoriatic Arthritis. / Orbai, Ana-Maria; Ogdie, Alexis.

In: Rheumatic Disease Clinics of North America, 2016.

Research output: Contribution to journalArticle

@article{305059995502404da73144ec3f0f9b31,
title = "Patient-Reported Outcomes in Psoriatic Arthritis",
abstract = "Patient-reported outcome (PRO) measures are an important component to assessing disease impact and therapy response in patients with psoriatic arthritis (PsA). Overall, there are few PsA-specific PROs. Most PROs used in PsA are borrowed from other diseases (eg, rheumatoid arthritis and ankylosing spondylitis) or general population PROs. PROs are used in PsA clinical trials and in the clinical management of PsA. In this review, we discuss the most commonly used PRO in PsA, including their inclusion in composite measures. Future studies may be helpful to determine the best performing PROs in patients with PsA.",
keywords = "Composite measures, Outcome measure, Patient reported outcome, Psoriatic arthritis",
author = "Ana-Maria Orbai and Alexis Ogdie",
year = "2016",
doi = "10.1016/j.rdc.2016.01.002",
language = "English (US)",
journal = "Rheumatic Disease Clinics of North America",
issn = "0889-857X",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Patient-Reported Outcomes in Psoriatic Arthritis

AU - Orbai, Ana-Maria

AU - Ogdie, Alexis

PY - 2016

Y1 - 2016

N2 - Patient-reported outcome (PRO) measures are an important component to assessing disease impact and therapy response in patients with psoriatic arthritis (PsA). Overall, there are few PsA-specific PROs. Most PROs used in PsA are borrowed from other diseases (eg, rheumatoid arthritis and ankylosing spondylitis) or general population PROs. PROs are used in PsA clinical trials and in the clinical management of PsA. In this review, we discuss the most commonly used PRO in PsA, including their inclusion in composite measures. Future studies may be helpful to determine the best performing PROs in patients with PsA.

AB - Patient-reported outcome (PRO) measures are an important component to assessing disease impact and therapy response in patients with psoriatic arthritis (PsA). Overall, there are few PsA-specific PROs. Most PROs used in PsA are borrowed from other diseases (eg, rheumatoid arthritis and ankylosing spondylitis) or general population PROs. PROs are used in PsA clinical trials and in the clinical management of PsA. In this review, we discuss the most commonly used PRO in PsA, including their inclusion in composite measures. Future studies may be helpful to determine the best performing PROs in patients with PsA.

KW - Composite measures

KW - Outcome measure

KW - Patient reported outcome

KW - Psoriatic arthritis

UR - http://www.scopus.com/inward/record.url?scp=84961124422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961124422&partnerID=8YFLogxK

U2 - 10.1016/j.rdc.2016.01.002

DO - 10.1016/j.rdc.2016.01.002

M3 - Article

JO - Rheumatic Disease Clinics of North America

JF - Rheumatic Disease Clinics of North America

SN - 0889-857X

ER -